[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100422449":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":25,"centralContacts":30,"locations":37,"responsibleParty":77,"collaborators":80,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":35,"enrollmentInfo":93,"targetDuration":35,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":103,"overallStatus":61,"whyStopped":35,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":117},{"fullName":5,"class":6},"Isala","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Post-PCI intra-coronary physiological and OCT measurements","After angiographically successful CTO PCI, intra-coronary physiologic assessment (RFR, FFR, CFR and IMR) and OCT of the CTO vessel will be performed directly. OCT may als be performed during a staged procedure within 4 ± 2 weeks after the index procedure when clinically indicated.",[12],"Diagnostic Test: post-PCI Pd\u002FPa",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","post-PCI Pd\u002FPa","After angiographically successful CTO PCI, intra-coronary physiologic assessment (RFR, FFR, CFR and IMR) and subsequent OCT of the CTO vessel will be performed. OCT may also be performed during a staged procedure when clinically indicated.",[9],[20,21,22,23,24],"Post-PCI RFR","Post-PCI CFR","Post-PCI IMR","Post-PCI FFR","Post-PCI OCT",[26],{"name":27,"affiliation":28,"role":29},"Maarten Van Leeuwen, PhD","Isala Zwolle","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Maarten van Leeuwen, PhD","CONTACT","0031 38 424 2374",null,"m.a.h.van.leeuwen@isala.nl",[38,60],{"facility":39,"status":40,"city":41,"state":35,"zip":35,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Radboud UMC","NOT_YET_RECRUITING","Nijmegen","Netherlands","NL",{"type":45,"coordinates":46},"Point",[47,48],5.85278,51.8425,{"lat":48,"lon":47},[51,54,57,58],{"name":52,"role":33,"phone":35,"phoneExt":35,"email":53},"Alexander Griffioen, MD, MSc","alexander.griffioen@radboudumc.nl",{"name":55,"role":33,"phone":35,"phoneExt":35,"email":56},"Robert Jan van Geuns, MD, PhD","robertjan.vangeuns@radboudumc.nl",{"name":55,"role":29,"phone":35,"phoneExt":35,"email":35},{"name":52,"role":59,"phone":35,"phoneExt":35,"email":35},"SUB_INVESTIGATOR",{"facility":5,"status":61,"city":62,"state":35,"zip":63,"country":42,"countryCode":43,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"RECRUITING","Zwolle","8025 AB",{"type":45,"coordinates":65},[66,67],6.09444,52.5125,{"lat":67,"lon":66},[70,72,75,76],{"name":71,"role":33,"phone":34,"phoneExt":35,"email":36},"Maarten Van Leeuwen, MD, PhD",{"name":73,"role":33,"phone":34,"phoneExt":35,"email":74},"Tom Meijers, MD, MSc","t.a.meijers@isala.nl",{"name":71,"role":29,"phone":35,"phoneExt":35,"email":35},{"name":73,"role":59,"phone":35,"phoneExt":35,"email":35},{"type":29,"investigatorFullName":78,"investigatorTitle":79,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"Maarten van Leeuwen","Principial Investigator Isala",[81],{"name":82,"class":83},"Abbott","INDUSTRY","100422449","use-of-physiology-to-evaluate-procedural-result-after-pci-cto-100422449",false,"NCT04780971","Use of Physiology to Evaluate Procedural Result After PCI CTO","ULTRA-CTO","Inclusion Criteria:\n\n1. Age 18 years and older.\n2. Angiographically successful PCI CTO without any remaining lesion at least 30% proximal to the stented segment.\n3. Possibility to perform physiologic measurements and OCT of sufficient quality.\n4. Patients willing and capable to provide written informed consent.\n\nExclusion Criteria:\n\n1\\) Contra-indication for adenosine.","ALL","18 Years",{"count":94,"type":95},200,"ESTIMATED","INTERVENTIONAL",[98],"NA","ULTRA-CTO is a prospective multicentre non-randomised investigator-initiated trial designed to enrol 200 subjects with an indication for percutaneous coronary intervention (PCI) of chronic total occluded (CTO) coronary artery.\n\nThe main objective of the study is to assess the predictive value of post-PCI resting full-cycle ratio (RFR) and fractional flow reserve (FFR) with regard to Fractional flow reserve (SSR) in CTO patients.",[101,102],"Percutaneous Coronary Revascularisation","Complex Coronary Lesion",[104,105,106,107],"percutaneous coronary intervention","chronic total occlusion","intra-coronary physiology","optical coherence tomography","2025-02-15",{"date":110,"type":111},"2025-02-19","ACTUAL",{"date":113,"type":111},"2021-07-21",{"date":115,"type":95},"2026-06",{"name":5,"class":6},2]